Pharmaceutical Contract Sales Organizations Market Size and Forecasts (2020 – 2030)

Pharmaceutical Contract Sales Organizations Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Send Enquiry
Item ID: TIPRE00030074 Category: Tags: , ,

$3,185$5,985

Description

The pharmaceutical contract sales organizations market size is expected to grow from US$ 8.212 billion in 2022 to US$ 15.820 billion by 2030; it is estimated to record a CAGR of 8.6% during 2022 to 2030.

The pharmaceutical contract sales organizations market growth is attributed to the increasing integration of digital technologies and the growing interest of pharmaceutical companies to increase sales of products.

The increasing use of telemedicine and remote detailing leads to new opportunities for the pharmaceutical contract sales organizations (CSO) market. The transformative influence of digital health technologies has redefined patient-doctor interactions and revolutionized the dynamics of pharmaceutical sales. With its capacity to facilitate virtual consultations and engagements, telemedicine creates a fertile ground for CSOs to adapt and innovate. Remote detailing, which involves using digital channels to communicate product information and engage healthcare professionals, becomes a strategic avenue for CSOs to extend their reach. This strategic change highlights the pharmaceutical industry’s proactive approach to navigating the market’s complexity. By working with CSOs, these businesses can access specialist sales personnel, leveraging outside expertise to increase market penetration and improve sales effectiveness. Through this collaborative model, pharmaceutical companies may streamline their operations and concentrate on key capabilities like research and development while utilizing the specific knowledge of CSOs to increase the marketability of their products. The rising cooperation between pharmaceutical corporations and CSOs demonstrates a dedication to adaptation and a profound grasp of the developing dynamics within the very competitive pharmaceutical industry. It also displays a nuanced understanding of resource optimization. This mutually beneficial partnership makes revenue maximization possible and strategically places pharmaceutical firms in a market where adaptability and focused market strategies are essential for long-term success.

End User-Based Insights

Based on end user, the pharmaceutical contract sales organizations market is segmented into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held a larger market share in 2022. Pharmaceutical companies are the major end users of contract sales organizations (CSOs). These companies utilize CSOs as strategic partners to bolster their sales and marketing endeavors, streamline market access, and optimize resource allocation.

Pharmaceutical companies are increasingly turning to CSO services due to the growing number of new small molecule drug launches worldwide, the presence of a significant number of pharmaceutical companies offering similar products, and the high adoption of new technologies for contract sales by companies. Moreover, recruiting and retaining efficient sales professionals for pharmaceutical companies is challenging; this supports the demand for CSO services for pharmaceutical companies. Pharmaceutical companies are increasingly looking to CSOs to help them build strong sales teams quickly, reduce sales team overhead costs, save time and effort on the recruitment process, and develop part-time contract sales teams to eliminate the need for investments. Thus, the growing focus of pharmaceutical companies on saving money and time is boosting sales opportunities for the pharmaceutical contract sales organizations market.

However, the biopharmaceutical companies segment is anticipated to register a higher CAGR during 2022–2030. Biopharmaceutical companies strategically employ CSOs to optimize various facets of their operations. These partnerships are instrumental in bolstering the sales and marketing activities of biopharmaceutical companies. CSOs provide a roster of experienced sales representatives specializing in biopharmaceutical products, enabling comprehensive product promotion and market penetration. They also provide the agility to scale sales efforts as needed without the long-term financial commitment of an in-house team. Such collaborations offer biopharmaceutical companies expertise, scalability, and cost efficiencies, allowing them to focus on innovation and research while leveraging the specialized skills and resources that CSOs provide for successful product commercialization.

Biopharmaceutical companies are focusing on improving their research capabilities. According to the Pharma R&D annual review, in 2022, more than 45% of the total drugs in the pipeline were biopharmaceuticals. Owing to the high interest of biopharmaceutical companies in research and boosting the sales of biopharmaceutical and small molecule drugs, it is expected that these companies will outsource their sales activities to CSOs in order to focus on their research capabilities, which in turn is anticipated to support the market growth for the segment.

Europe is the second leading region in the market. The demand for pharmaceutical products is growing significantly in this region with the burgeoning prevalence of chronic diseases, the rising geriatric population, and increasing demand for new drug molecules for various therapeutic applications to fulfill unmet needs. Nearly 550 pharmaceutical companies have operations in Germany. Contract sales organizations (CSOs) in this country provide their services to large pharmaceutical companies and small-scale biotech companies, assisting them in attaining leading positions in the European market. As per data by Germany Trade & Invest, pharmaceutical sales in Germany increased by 6.7% in 2020 compared to 2019, reaching US$ 60.79 billion (EUR 49.5 billion).

Major pharmaceutical companies in Belgium include Janssen Pharmaceutica, Solvay, UCB (Union Chimique Belge), and GMED Healthcare, as well as subsidiaries such as BASF Antwerpen and GlaxoSmithKline Biologicals. Further, most leading multinationals—including Pfizer, Sanofi-Aventis, Novartis, GlaxoSmithKline, and AstraZeneca—have a direct presence in Spain. The presence of such pharmaceutical giants has strengthened the European pharmaceutical market. Sales growth strategies adopted by market players are anticipated to drive the pharmaceutical contract sales organizations market in the region. CSO helps attain brand success and secure the financial viability of an emerging pharmaceutical company. Their expertise in areas such as market analysis and targeting analysis helps pharmaceutical companies surpass their target goals. CSOs leverage data analytics tools to gather market insights, track product performance, and identify opportunities. This data-driven approach allows for more targeted marketing and sales efforts. They use machine learning and AI algorithms to analyze data, predict sales trends, and personalize marketing content. Therefore, the proliferating pharmaceutical and biopharmaceutical industries, owing to the presence of top pharmaceutical companies, collaborations of pharmaceutical companies with CSOs, and the strategic efforts of market players to enhance their reach, fuel the growth of the pharmaceutical contract sales organizations market in Europe.

Germany Trade & Invest, GLOBOCAN, the Centers for Disease Control and Prevention (CDC), and the World Health Organization (WHO) are among the primary and secondary sources referred to while preparing the pharmaceutical contract sales organizations market report.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

Commercial Services Segment by Services to Account Larger Share in Pharmaceutical Contract Sales Organizations Market during 2022–2030

According to our latest study on “pharmaceutical contract sales organizations market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis” the market is expected to grow from US$ 8.212 billion in 2022 and is expected to reach US$ 15.820 billion by 2030; it is anticipated to record a CAGR of 8.6% from 2022 to 2030. The report highlights the key factors driving the pharmaceutical contract sales organizations market growth and prominent players with their developments in the market.

Pharmaceutical companies may outsource their sales and marketing functions to third parties, commonly referred to as contract sales organizations, under the pharmaceutical contract sales outsourcing (CSO) business model. Because of the financial benefits, the improved flexibility, and the easy access to specialized knowledge, this practice has gained popularity in the pharmaceutical sector. Companies that manage contract sales teams also offer training, hiring, and performance evaluation. Contract sales outsourcing does, however, come with some drawbacks, including the potential loss of sales process control and the requirement to uphold solid vendor relationships.

The pharmaceutical contract sales organizations market: by service, is segmented into commercial services and non-commercial services. In 2022, the commercial services segment held the largest share of the market and is expected to grow at the fastest rate during the coming years. Commercial services refer to the range of services provided by contract sales organizations (CSOs) to pharmaceutical companies to support their sales and marketing efforts. CSOs are third-party organizations specializing in delivering sales and marketing services on behalf of pharmaceutical companies.

The pharmaceutical contract sales organizations market, by module, is segmented into syndicated modules and dedicated modules. In 2022, the syndicated modules segment held the largest share of the market and is expected to grow at the fastest rate during the coming years. Syndicate modules refer to a collaborative approach where multiple pharmaceutical companies join forces to share resources and expertise in order to achieve common sales and marketing goals. These modules allow the companies to form a unified team that promotes and sells the products of all participating companies.

The pharmaceutical contract sales organizations market, by therapeutic area, is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. In 2022, the oncology segment held the largest share of the market. Oncology is one of the world’s fastest-moving therapeutic areas, and it is expected to represent a major part of pharmaceutical sales in the future, creating a growing demand for pharmaceutical contract sales outsourcing in the oncology therapeutic area.

The pharmaceutical contract sales organizations market, by end user, is segmented into biopharmaceutical companies and pharmaceutical companies. In 2022, the pharmaceutical companies segment held the largest share of the market.

CMIC Holdings Co., Ltd., Axxelus, EPS Holdings, Inc., MaBico, IQVIA, Inc., Peak PharmA, QFR Solutions, Promoveo Health, Syneous Health Inc., Mednext Pharmaceuticals Pvt. Ltd are among the leading companies operating in the global Diabetic Foot Ulcer market.

Companies operating in the pharmaceutical contract sales organizations market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies in the breast cancer therapeutics market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall pharmaceutical contract sales organizations market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

A few of the significant developments by key market players are listed below.

• In September 2021, Leading contract research business (CRO) PRA Health Sciences was acquired by ICON plc. ICON’s position in the CRO market is anticipated to improve as a result of the acquisition.

• In September 2022, pharmaceutical organization Dr. Reddy’s Laboratories partnered with IQVIA, Inc. In accordance with the arrangement, IQVIA gave Dr. Reddy’s access to its Orchestrated Customer Engagement (OCE) platform to assist with its CRM operations. According to the deal, Dr. Reddy’s gave IQVIA’s OCE application to all its marketing users and field staff in India so they could more effectively engage customers by integrating marketing, account management, medical scientific liaison, sales, and other activities.

• In November 17, 2020, Expert Medical Navigation (EMN), a provider of medical affairs solutions for pharmaceutical firms, was acquired by PDI. The acquisition is anticipated to increase PDI’s capacity for medical affairs.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Adaptive Traffic Control System Market Landscape
4.1 Market Overview
4.2 Middle East & Africa PEST Analysis
4.3 Ecosystem Analysis
4.4 Expert Opinions
5. Middle East & Africa Adaptive Traffic Control System Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Urban Population and Vehicle Sales
5.1.2 Growing Investments in Roadway Infrastructure
5.2 Market Restraints
5.2.1 Increasing Security Threats
5.3 Market Opportunities
5.3.1 Development of Smart Cities
5.4 Future Trends
5.4.1 Growing Adoption of AI in Traffic Management Systems
5.5 Impact Analysis of Drivers and Restraints
6. Adaptive Traffic Control System Market – Middle East & Africa Market Analysis
6.1 Middle East & Africa Adaptive Traffic Control System Market Overview
6.2 Middle East & Africa Adaptive Traffic Control System Market- Forecast and Analysis
7. Middle East & Africa Adaptive Traffic Control System Market Revenue and Forecast to 2030 – Component
7.1 Overview
7.2 Middle East & Africa Adaptive Traffic Control System Market Breakdown, By Application, 2022 and 2030
7.3 Hardware
7.3.1 Overview
7.3.2 Hardware : Middle East & Africa Adaptive Traffic Control System Market- Forecast and Analysis
7.4 Software
7.4.1 Overview
7.4.2 Software : Middle East & Africa Adaptive Traffic Control System Market- Forecast and Analysis
7.5 Services
7.5.1 Overview
7.5.2 Services : Middle East & Africa Adaptive Traffic Control System Market- Forecast and Analysis
8. Middle East & Africa Adaptive Traffic Control System Market Analysis – By Type
8.1 Overview
8.2 Middle East & Africa Adaptive Traffic Control System Market Breakdown, by Type, 2022 and 2030
8.3 OPAC
8.3.1 Overview
8.3.2 OPAC : Middle East & Africa Adaptive Traffic Control System Market – Revenue and Forecast to 2030 (US$ Million)
8.4 SCOOT
8.4.1 Overview
8.4.2 SCOOT : Middle East & Africa Adaptive Traffic Control System Market – Revenue and Forecast to 2030 (US$ Million)
8.5 RHODES
8.5.1 Overview
8.5.2 RHODES : Middle East & Africa Adaptive Traffic Control System Market – Revenue and Forecast to 2030 (US$ Million)
8.6 SCATS
8.6.1 Overview
8.6.2 SCATS : Middle East & Africa Adaptive Traffic Control System Market – Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Adaptive Traffic Control System Market Revenue and Forecast to 2030 – Application
9.1 Overview
9.2 Middle East & Africa Adaptive Traffic Control System Market Breakdown, by Application, 2022 and 2030
9.3 Highways
9.3.1 Overview
9.3.2 Highways : Middle East & Africa Adaptive Traffic Control System Market- Forecast and Analysis
9.4 Urban (Cities)
9.4.1 Overview
9.4.2 Urban (Cities) : Middle East & Africa Adaptive Traffic Control System Market- Forecast and Analysis
10. Middle East & Africa Adaptive Traffic Control System Market – Country Analysis
10.1 Overview
10.1.1 Middle East & Africa Adaptive Traffic Control System Market, by Key Country
10.1.1.1 South Africa: Middle East & Africa Adaptive Traffic Control System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 South Africa: Middle East & Africa Adaptive Traffic Control System Market, by Component
10.1.1.1.2 South Africa: Middle East & Africa Adaptive Traffic Control System Market, by Type
10.1.1.1.3 South Africa: Middle East & Africa Adaptive Traffic Control System Market, by Application
10.1.1.2 Saudi Arabia: Middle East & Africa Adaptive Traffic Control System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Saudi Arabia: Middle East & Africa Adaptive Traffic Control System Market, by Component
10.1.1.2.2 Saudi Arabia: Middle East & Africa Adaptive Traffic Control System Market, by Type
10.1.1.2.3 Saudi Arabia: Middle East & Africa Adaptive Traffic Control System Market, by Application
10.1.1.3 UAE: Middle East & Africa Adaptive Traffic Control System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 UAE: Middle East & Africa Adaptive Traffic Control System Market, by Component
10.1.1.3.2 UAE: Middle East & Africa Adaptive Traffic Control System Market, by Type
10.1.1.3.3 UAE: Middle East & Africa Adaptive Traffic Control System Market, by Application
10.1.1.4 Rest of Middle East & Africa: Middle East & Africa Adaptive Traffic Control System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Rest of Middle East & Africa: Middle East & Africa Adaptive Traffic Control System Market, by Component
10.1.1.4.2 Rest of Middle East & Africa: Middle East & Africa Adaptive Traffic Control System Market, by Type
10.1.1.4.3 Rest of Middle East & Africa: Middle East & Africa Adaptive Traffic Control System Market, by Application
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Product Development
11.4 Mergers & Acquisitions
12. Company Profiles
12.1 Aldridge Traffic Controllers Pty Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 EFKON India Pvt. Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Kapsch TrafficCom AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Johnson Controls International Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 No Traffic
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Kimley-Horn and Associates Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About
13.2 Word Index

LIST OF TABLES

Table 1. Pharmaceutical Contract Sales Organizations Market Segmentation
Table 4. North America Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 5. North America Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 6. North America Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 7. North America Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 8. North America Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 9. North America Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 10. US Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 11. US Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 12. US Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 13. US Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 14. US Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 15. US Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 16. Canada Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 17. Canada Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 18. Canada Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 19. Canada Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 20. Canada Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 21. Canada Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 22. Mexico Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 23. Mexico Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 24. Mexico Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 25. Mexico Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 26. Mexico Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 27. Mexico Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 28. Europe Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 29. Europe Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 30. Europe Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 31. Europe Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 32. Europe Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 33. Europe Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 34. UK Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 35. UK Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 36. UK Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 37. UK Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 38. UK Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 39. UK Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 40. Germany Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 41. Germany Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 42. Germany Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 43. Germany Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 44. Germany Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 45. Germany Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 46. France Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 47. France Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 48. France Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 49. France Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 50. France Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 51. France Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 52. Italy Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 53. Italy Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 54. Italy Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 55. Italy Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 56. Italy Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 57. Italy Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 58. Spain Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 59. Spain Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 60. Spain Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 61. Spain Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 62. Spain Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 63. Spain Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 64. Rest of Europe Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 65. Rest of Europe Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 66. Rest of Europe Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 67. Rest of Europe Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 68. Rest of Europe Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 69. Rest of Europe Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 70. Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 71. Asia Pacific Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 72. Asia Pacific Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 73. Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 74. Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 75. Asia Pacific Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 76. China Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 77. China Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 78. China Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 79. China Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 80. China Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 81. China Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 82. Japan Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 83. Japan Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 84. Japan Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 85. Japan Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 86. Japan Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 87. Japan Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 88. India Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 89. India Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 90. India Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 91. India Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 92. India Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 93. India Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 94. Australia Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 95. Australia Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 96. Australia Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 97. Australia Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 98. Australia Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 99. Australia Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 100. South Korea Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 101. South Korea Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 102. South Korea Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 | (US$ Million)
Table 103. South Korea Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 104. South Korea Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 105. South Korea Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 106. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 107. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 108. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 109. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 110. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 111. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 112. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 113. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 114. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 115. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 116. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 117. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 118. Saudi Arabia Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 119. Saudi Arabia Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 120. Saudi Arabia Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 121. Saudi Arabia Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 122. Saudi Arabia Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 123. Saudi Arabia Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 124. UAE Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 125. UAE Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 126. UAE Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 127. UAE Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 128. UAE Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 129. UAE Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 130. South Africa Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 131. South Africa Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 132. South Africa Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 133. South Africa Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 134. South Africa Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 135. South Africa Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 136. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 137. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 138. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 139. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 140. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 141. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 142. South & Central America Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 143. South & Central America Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 144. South & Central America Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 145. South & Central America Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 146. South & Central America Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 147. South & Central America Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 148. Brazil Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 149. Brazil Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 150. Brazil Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 151. Brazil Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 152. Brazil Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 153. Brazil Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 154. Argentina Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 155. Argentina Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 156. Argentina Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 157. Argentina Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 158. Argentina Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 159. Argentina Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 160. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)
Table 161. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 162. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)
Table 163. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)
Table 164. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 165. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)
Table 166. Recent Organic Growth Strategies in Pharmaceutical Contract Sales Organizations Market
Table 167. Recent Inorganic Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
Table 168. Glossary of Terms, Pharmaceutical Contract Sales Organizations Market

LIST OF FIGURES

Figure 1. Pharmaceutical Contract Sales Organizations Market Segmentation, By Geography
Figure 2. Global – PEST Analysis
Figure 3. Pharmaceutical Contract Sales Organizations Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Pharmaceutical Contract Sales Organizations Market Revenue, Geography (US$ Mn), 2022 – 2030
Figure 7. Pharmaceutical Contract Sales Organizations Market Revenue Share, by Product Type, 2022 & 2030 (%)
Figure 8. Reagents and Assay Kits: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Instruments: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Pharmaceutical Contract Sales Organizations Market Revenue Share, by Module 2022 & 2030 (%)
Figure 11. Tandem Mass Spectrometry (TMS): Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Molecular Assays: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Immunoassays and Enzymatic Assays: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Pulse Oximetry Screening Technology: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Other Technologies: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area 2022 & 2030 (%)
Figure 17. Dry Blood Spot Test: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Hearing Screen Test: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Critical Congenital Heart Diseases (CCHD) Test: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Other Test Types: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 22. Hospitals and Clinics: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Diagnostic Laboratories: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. North America: Pharmaceutical Contract Sales Organizations Market , by Key Country – Revenue (2022) (US$ Million)
Figure 25. North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. North America Pharmaceutical Contract Sales Organizations Market , By Key Countries, 2022 and 2030 (%)
Figure 27. US Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Canada Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Mexico Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Europe Pharmaceutical Contract Sales Organizations Market , by Key Country – Revenue, 2022 (US$ Million)
Figure 31. Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Europe Pharmaceutical Contract Sales Organizations Market , By Key Countries, 2022 and 2030 (%)
Figure 33. UK Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Germany Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. France Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Italy Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Spain Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. Rest of Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Key Country – Revenue, 2022 (US$ Million)
Figure 40. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Asia Pacific Pharmaceutical Contract Sales Organizations Market , By Key Countries, 2022 and 2030 (%)
Figure 42. China Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Japan Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 44. India Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 45. Australia Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 46. South Korea Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 47. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 48. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Key Country – Revenue, 2022 (US$ Million)
Figure 49. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 50. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , By Key Countries, 2022 and 2030 (%)
Figure 51. Saudi Arabia Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. UAE Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 53. South Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 54. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. South & Central America Pharmaceutical Contract Sales Organizations Market , by Key Country – Revenue, 2022 (US$ Million)
Figure 56. South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 57. South & Central America Pharmaceutical Contract Sales Organizations Market , By Key Countries, 2022 and 2030 (%)
Figure 58. Brazil Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. Argentina Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 60. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 61. Growth Strategies in Pharmaceutical Contract Sales Organizations Market

The List of Companies – Pharmaceutical Contract Sales Organizations Market
– CMIC Holdings Co., Ltd.
– Axxelus
– EPS Holdings, Inc. 
– MaBico
– IQVIA, Inc.
– Peak Pharma
– QFR Solutions
– Promoveo Health
– Syneous Health Inc.
– Mednext Pharmaceuticals Pvt. Ltd

Reviews

There are no reviews yet.

Be the first to review “Pharmaceutical Contract Sales Organizations Market Size and Forecasts (2020 – 2030)”